Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 39 of 39 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami is developing therapies to address the unmet medical needs of people with serious and rare forms of pulmonary hypertension, including pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. | Location Durham | |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham | |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville | |
Company Basking Biosciences Inc. | Activity: Research and Development | Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. | Location Research Triangle Park | |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville | |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh | |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill | |
Company Cessation Therapeutics | Activity: Sales and Operations | Company Description Cessation Therapeutics is developing novel antibody therapies to prevent and reverse overdose related to fentanyl and related synthetic opioids. The Chapel Hill site is Cessation's corporate office. | Location Chapel Hill | |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville | |
Company Doron Therapeutics | Activity: Research and Development | Company Description Doron Therapeutics is developing an injectable biologic to treat osteoarthritis and other musculoskeletal diseases. | Location Chapel Hill | |
Company DotBio LLC | Activity: Research and Development | Company Description DotBio develops immuno-oncology therapies. | Location Weddington | |
Company Dualogics LLC | Activity: Research and Development | Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. | Location Durham | |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham | |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham | |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham | |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh | |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham | |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville | |
Company Invitrox Inc. | Activity: Contract Research and Testing | Company Description Invitrox provides GLP-compliant bioanalytical services for nonclinical and clinical drug development studies, with expertise in method development and validation, small and large molecules, sample analysis, metabolites, biomarkers and drug monitoring. | Location Research Triangle Park | |
Company Istari Oncology Inc. | Activity: Research and Development | Company Description ISTARI Oncology is developing immunotherapies for cancer treatment. | Location Morrisville | |
Company Kaio Therapy LLC | Activity: Research and Development | Company Description KAIO Therapy develops an immunotherapy technology to treat solid tumors. | Location Raleigh | |
Company Lindy Biosciences Inc. | Activity: Research and Development | Company Description Lindy Biosciences develops protein therapeutic formulations for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release) or dry powder pulmonary delivery. | Location Morrisville | |
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham | |
Company Novex Innovations LLC | Activity: Production and Manufacturing | Company Description Novex Innovations is a contract development and manufacturing organization (CDMO) supporting large, medium, small and startup life science companies in the development of their products, from concept through manufacturing and commercialization. | Location Winston-Salem | |
Company On.Target Molecules Biotech Inc. | Activity: Research and Development | Company Description O.TM Biotech is developing anti-cancer monoclonal antibodies using a novel technology platform to accelerate advancements in cancer therapeutics. | Location Wilmington | |
Company OncoTAb Inc. | Activity: Research and Development | Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. | Location Charlotte | |
Company Phenom Pharmaceuticals LLC | Activity: Research and Development | Company Description Phenom Pharmaceuticals develops preventatives and therapeutics. | Location Charlotte | |
Company PhosphoGam Inc. | Activity: Research and Development | Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. | Location Durham | |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill | |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham | |
Company Relevant Biosciences Inc. | Activity: Research and Development | Company Description Relevant Bio develops natural antibody-based cancer therapeutics. | Location Raleigh | |
Company Resilient Biotics Inc. | Activity: Research and Development | Company Description Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species. | Location Durham | |
Company Resolian (Raleigh) | Activity: Sales and Operations | Company Description Resolian is a global contract research organization specializing in bioanalytics for small and large molecules, Drug Metabolism and Pharmacokinetics (DMPK) and analytical services supporting CMC. The Raleigh office is a commercial office. | Location Raleigh | |
Company Shattuck Labs Inc. | Activity: Research and Development | Company Description Shattuck Labs is a preclinical-stage immunotherapy company focused on utilizing its proprietary ARC (Agonist Redirected Checkpoint) technology to develop novel treatments for use in cancer, inflammation and orphan disease. | Location Durham | |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte | |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary | |
Company Symberix Inc. | Activity: Research and Development | Company Description Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases such as Inflammatory Bowel Disorder (IBD) as well as mitigate the lower GI side effects associated with various pain, cancer and immunosuppressive therapies. | Location Durham | |
Company TCRCure Biopharma Corp. | Activity: Research and Development | Company Description TCRCure Biopharma discovers and develops novel therapeutic targets in the field of cancer immunotherapy. | Location Durham | |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary |